[1]树叶,谈鑫,刘向宇,等.口服西罗莫司治疗小儿脉管异常类疾病的效果观察[J].临床小儿外科杂志,2021,20(11):1064-1069.[doi:10.12260/lcxewkzz.2021.11.013]
 Shu Ye,Tan Xin,Liu Xiangyu,et al.Study of oral sirolimus in the treatment of vascular anomaliesin infants and children[J].Journal of Clinical Pediatric Surgery,2021,20(11):1064-1069.[doi:10.12260/lcxewkzz.2021.11.013]
点击复制

口服西罗莫司治疗小儿脉管异常类疾病的效果观察

参考文献/References:

1 孔亮亮, 韩涛, 高庆文, 等. 口服西罗莫司治疗难治性脉管性疾病的有效性与安全性[J].中华整形外科杂志, 2020, 36(5):487-493.DOI:10.3760/cma.j.cn114453-20200316-00159. Kong LL, Han T, Gao QW, et al. Efficacy and safety of oral sirolimus in the treatment of refractory vascular anomalies[J].Chin J Plast Surg, 2020, 36(5):487-493.DOI:10.3760/cma.j.cn114453-20200316-00159.
2 赵亚梅, 高怡瑾, 周莺, 等. 儿童卡梅现象13例回顾性分析并文献复习[J].临床儿科杂志, 2017, 35(6):458-466.DOI:10.3969/j.issn.1000-3606.2017.06.015. Zhao YM, Gao YJ, Zhou Y, et al. Retrospective analysis in 13 children with Kasabach-Merritt phenomenon and review of literature[J].J Clin Pediatr, 2017, 35(6):458-466.DOI:10.3969/j.issn.1000-3606.2017.06.015.
3 代诗懿, 彭素华, 陈思源, 等. 卡波西样血管内皮瘤的研究进展[J].临床小儿外科杂志, 2020, 19(6):544-547.DOI:10.3969/j.issn.1671-6353.2020.06.016. Dai SY, Peng SH, Chen SY, et al. Recent advances in researches and treatments of kaposiform hemangioendothelioma[J].J Clin Ped Sur, 2020, 19(6):544-547.DOI:10.3969/j.issn.1671-6353.2020.06.016.
4 中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形的诊断及治疗指南(2019 版)[J]. 组织工程与重建外科杂志, 2019, 15(5):277-317.DOI:10.3969/j.issn.1673-0364.2019.05.001. Group of Angiomas and Vascular Malformations, Branch of Reconstructive Surgery, Chinese Medical Association:Guideline of Diagnosing & Treating Angiomas and Vascular Malformations (2019 Edition)[J].Journal of Tissue Engineering and Reconstructive Surgery, 2019, 15(5):277-317.DOI:10.3969/j.issn.1673-0364.2019.05.001.
5 刘文英.脉管异常类疾病的分类及相关临床问题[J].临床小儿外科杂志, 2019, 18(8):621-625.DOI:10.3969/j.issn.1671-6353.2019.08.001. Liu WY.Classifications and clinical managements of vascular abnormalities[J].J Clin Ped Sur, 2019, 18(8):621-625.DOI:10.3969/j.issn.1671-6353.2019.08.001.
6 Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children[J].Pediatr Blood Cancer, 2011, 57(6):1018-1024.DOI:10.1002/pbc.23124.
7 ?zg?nenel B, Martin A.Low-dose sirolimus controls recurrent iron deficiency in a patient with blue rubber bleb nevus syndrome[J].Pediatr Blood Cancer, 2015, 62(11):2054-2055.DOI:10.1002/pbc.25590.
8 Hammer J, Seront E, Duez S, et al. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations:a monocentric prospective phase Ⅱ study[J].Orphanet J Rare Dis, 2018, 13(1):191.DOI:10.1186/s13023-018-0934-z.
9 Nozawa A, Ozeki M, Yasue S, et al. Immunologic Effects of Sirolimus in Patients With Vascular Anomalies[J].J Pediatr Hematol Oncol, 2020, 42(5):e355-e360.DOI:10.1097/MPH.0000000000001650.
10 Russell TB, Rinker EK, Dillingham CS, et al. Pneumocystis Jirovecii Pneumonia during sirolimus therapy for kaposiform hemangioendothelioma[J].Pediatrics, 2018, 141(Suppl5):S421-S424.DOI:10.1542/peds.2017-1044.
11 Ying H, Qiao C, Yang X, et al. A case report of 2 sirolimus-related deaths among infants with kaposiform hemangioendotheliomas[J].Pediatrics, 2018, 141(Suppl5):S425-S429.DOI:10.1542/peds.2016-2919.
12 Ji Y, Yang K, Chen S, et al. Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon:clinical characteristics and management[J].Cancer ManagRes, 2018, 10(9):3325-3331.DOI:10.2147/CMAR.S171223.eCollection 2018.
13 Ji Y, Chen S, Li L, et al. Kaposiform hemangioendothelioma without cutaneous involvement[J].J Cancer Res Clin Oncol, 2018, 144(12):2475-2484.DOI:10.1007/s00432-018-2759-5.
14 Schmid I, Klenk AK, Sparber-Sauer M, et al. Kaposiform hemangioendothelioma in children:a benign vascular tumor with multiple treatment options[J].World J Pediatr, 2018, 14(4):322-329.DOI:10.1007/s12519-018-0171-5.
15 Greveling K, Prens EP, van Doorn MB.Treatment of port wine stains using pulsed dye laser, erbium yag laser, and topical rapamycin (sirolimus)-a randomized controlled trial[J].Lasers Surg Med, 2017, 49(1):104-109.DOI:10.1002/lsm.22548.
16 Marqués L, Nú?ez-Córdoba JM, Aguado L, et al. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome:phase Ⅱ, randomized, double-blind, intraindividual placebo-controlled clinical trial[J].J Am Acad Dermatol, 2015, 72(1):151-158.e1.DOI:10.1016/j.jaad.2014.10.011.
17 Freixo C, Ferreira V, Martins J, et al. Efficacy and safety of sirolimus in the treatment of vascular anomalies:A systematic review[J].J Vasc Surg, 2020, 71(1):318-327.DOI:10.1016/j.jvs.2019.06.217.

相似文献/References:

[1]丁颖菁,李凯.西罗莫司在小儿卡波西型血管内皮瘤中的应用进展[J].临床小儿外科杂志,2022,21(10):987.[doi:10.3760/cma.j.cn101785-202008017-015]
 Ding Yingjing,Li Kai.Current applications and future perspectives of sirolimus in the treatment of kaposiform hemangioendothelioma[J].Journal of Clinical Pediatric Surgery,2022,21(11):987.[doi:10.3760/cma.j.cn101785-202008017-015]
[2]李楠,王健俊,黄昭榕,等.婴儿肝门部血管内皮瘤合并Kasabach-Merritt综合征引起胆道梗阻1例及文献复习[J].临床小儿外科杂志,2023,22(05):471.[doi:10.3760/cma.j.cn101785-202202001-013]
 Li Nan,Wang Jianjun,Huang Zhaorong,et al.Infant hepatic hilar hemangioendothelioma plus Kasabach-Merritt syndrome causing biliary obstruction:one case report and literature review[J].Journal of Clinical Pediatric Surgery,2023,22(11):471.[doi:10.3760/cma.j.cn101785-202202001-013]
[3]兰钰茹,周江元,邱桐,等.西罗莫司治疗复杂性脉管异常的研究进展[J].临床小儿外科杂志,2024,(07):693.[doi:10.3760/cma.j.cn101785-202202017-017]
 Lan Yuru,Zhou Jiangyuan,Qiu Tong,et al.Advances in research on the treatment of complicated vascular diseases with sirolimus[J].Journal of Clinical Pediatric Surgery,2024,(11):693.[doi:10.3760/cma.j.cn101785-202202017-017]

备注/Memo

收稿日期:2020-03-25。
基金项目:湖南省科技创新计划项目(编号:2018SK50408)
通讯作者:周斌,Email:zhoubin957@sina.com

更新日期/Last Update: 1900-01-01